PUBLICATIONS · 19853510
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2010 Jan
- First author
- Rajkumar SV
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2010 Jan;11(1):14
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- citation
- Lancet Oncol. 2010 Jan;11(1):3-4. doi: 10.1016/S1470-2045(09)70313-4.
- note
- Source null
- related pmid
- 19853511
- relationship
- Comment in
Authors and identifiers
- name
- Rajkumar SV
- type
- Author
- name
- Jacobus S
- type
- Author
- name
- Callander NS
- type
- Author
- name
- Fonseca R
- type
- Author
- name
- Vesole DH
- type
- Author
- name
- Williams ME
- type
- Author
- name
- Abonour R
- type
- Author
- name
- Siegel DS
- type
- Author
- name
- Katz M
- type
- Author
- name
- Greipp PR
- type
- Author
- name
- Eastern Cooperative Oncology Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Rajkumar SV
- type
- Author
- name
- Jacobus S
- type
- Author
- name
- Callander NS
- type
- Author
- name
- Fonseca R
- type
- Author
- name
- Vesole DH
- type
- Author
- name
- Williams ME
- type
- Author
- name
- Abonour R
- type
- Author
- name
- Siegel DS
- type
- Author
- name
- Katz M
- type
- Author
- name
- Greipp PR
- type
- Author
- name
- Eastern Cooperative Oncology Group
- type
- CollectiveName
- bibliography ids
- nci-bib-cef91cdc778ca5e9e64094cc
- book metadata
- content sha256
- 4a763bf3deb35788b2a88b7b21295b6058a31e9771bd4e6ece02777e7310471a
- document type
- citation
- dois
- 10.1016/S1470-2045(09)70284-0
- electronic publication date
- display
- 2009 Oct 21
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19853510
- immutable id
- pubmed:19853510@4a763bf3deb35788b2a88b7b21295b6058a31e9771bd4e6ece02777e7310471a
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 1
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 29-37
- volume
- 11
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2010 Jan;11(1):14
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- citation
- Lancet Oncol. 2010 Jan;11(1):3-4. doi: 10.1016/S1470-2045(09)70313-4.
- note
- Source null
- related pmid
- 19853511
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 19853510
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- 6a7f7dd9cca4e52963d547797c2f4ca7c4214afc544db86c490c0fd458dcf17a
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2010 Jan
- precision
- month
- year
- 2010
- publication types
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, U.S. Gov't, Non-P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.
Preserved source evidence · Not medical advice
Triangle